Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes
S. Krüger, S. Ewig, R. Marre, J. Papassotiriou, K. Richter, H. von Baum, N. Suttorp, T. Welte the CAPNETZ study group
European Respiratory Journal 2007; DOI: 10.1183/09031936.00054507
S. Krüger
S. Ewig
R. Marre
J. Papassotiriou
K. Richter
H. von Baum
N. Suttorp
This is a PDF-only article. The first page of the PDF of this article appears above.
Vol 63 Issue 4
Table of Contents
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes
S. Krüger, S. Ewig, R. Marre, J. Papassotiriou, K. Richter, H. von Baum, N. Suttorp, T. Welte
European Respiratory Journal Oct 2007, DOI: 10.1183/09031936.00054507